_id
691b1ae63c536f8df2318c7d
Ticker
ADXN.SW
Name
Addex Therapeutics Ltd
Exchange
SW
Address
Chemin des Mines, 9, Geneva, Switzerland, 1202
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Currency
CHF
Website
https://www.addextherapeutics.com
Description
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Last Close
0.0558
Volume
306191
Current Price
0.0522
Change
-0.0004
Last Updated
2026-01-01T00:01:13.167Z
Image
https://logo.clearbit.com/www.addextherapeutics.com
Ipo Date
-
Market Cap
8190323
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
2
Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
29724
Cost Of Revenue
-
Gross Profit
29724
Operating Expenses
725899
Operating Income
-696175
Interest Expense
472
Pretax Income
-1577231
Net Income
-1577231
Eps
-0.01399781323522963
Dividends Per Share
0
Shares Outstanding
147839777
Income Tax Expense
-
EBITDA
-1574641
Operating Margin
-2342.130937962589
Total Other Income Expense Net
-881056
Cash
2187202
Short Term Investments
6860
Receivables
51247
Inventories
-
Total Current Assets
2364724
Property Plant Equipment
36355
Total Assets
7330802
Payables
406141
Short Term Debt
7585
Long Term Debt
28960
Total Liabilities
1372247
Equity
5958555
Bs_currency_symbol
CHF
Depreciation
2118
Change In Working Capital
143412
Cash From Operations
-533203
Capital Expenditures
0
Cash From Investing
60074
Cash From Financing
361012
Net Change In Cash
-113792
Cf_currency_symbol
CHF
PE
-
PB
0.9871079742320077
ROE
-26.4700250312366
ROA
-21.515122083504643
FCF
-533203
Fcf Percent
-17.938467231866504
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
29724
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
29724
Quarters > 0 > income Statement > operating Expenses
725899
Quarters > 0 > income Statement > operating Income
-696175
Quarters > 0 > income Statement > interest Expense
472
Quarters > 0 > income Statement > pretax Income
-1577231
Quarters > 0 > income Statement > net Income
-1577231
Quarters > 0 > income Statement > eps
-0.01399781323522963
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
112676957
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1574641
Quarters > 0 > income Statement > operating Margin
-2342.130937962589
Quarters > 0 > income Statement > total Other Income Expense Net
-881056
Quarters > 0 > income Statement > currency_symbol
CHF
Quarters > 0 > balance Sheet > cash
2187202
Quarters > 0 > balance Sheet > short Term Investments
6860
Quarters > 0 > balance Sheet > receivables
51247
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2364724
Quarters > 0 > balance Sheet > property Plant Equipment
36355
Quarters > 0 > balance Sheet > total Assets
7330802
Quarters > 0 > balance Sheet > payables
406141
Quarters > 0 > balance Sheet > short Term Debt
7585
Quarters > 0 > balance Sheet > long Term Debt
28960
Quarters > 0 > balance Sheet > total Liabilities
1372247
Quarters > 0 > balance Sheet > equity
5958555
Quarters > 0 > balance Sheet > currency_symbol
CHF
Quarters > 0 > cash Flow > net Income
-1577231
Quarters > 0 > cash Flow > depreciation
2118
Quarters > 0 > cash Flow > change In Working Capital
143412
Quarters > 0 > cash Flow > cash From Operations
-533203
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
60074
Quarters > 0 > cash Flow > cash From Financing
361012
Quarters > 0 > cash Flow > net Change In Cash
-113792
Quarters > 0 > cash Flow > currency_symbol
CHF
Quarters > 0 > ratios > PE
-0.01399781323522963
Quarters > 0 > ratios > PB
0.9871079742320077
Quarters > 0 > ratios > ROE
-26.4700250312366
Quarters > 0 > ratios > ROA
-21.515122083504643
Quarters > 0 > ratios > FCF
-533203
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-17.938467231866504
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
36375
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
34257
Quarters > 1 > income Statement > operating Expenses
732898
Quarters > 1 > income Statement > operating Income
-732898
Quarters > 1 > income Statement > interest Expense
829
Quarters > 1 > income Statement > pretax Income
-1958912
Quarters > 1 > income Statement > net Income
-1841165
Quarters > 1 > income Statement > eps
-0.01831581542631229
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
100523234
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1955965
Quarters > 1 > income Statement > operating Margin
-2014.8398625429554
Quarters > 1 > income Statement > total Other Income Expense Net
-1226014
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
2300994
Quarters > 1 > balance Sheet > short Term Investments
6994
Quarters > 1 > balance Sheet > receivables
38439
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2657580
Quarters > 1 > balance Sheet > property Plant Equipment
38474
Quarters > 1 > balance Sheet > total Assets
8506015
Quarters > 1 > balance Sheet > payables
640087
Quarters > 1 > balance Sheet > short Term Debt
14982
Quarters > 1 > balance Sheet > long Term Debt
30900
Quarters > 1 > balance Sheet > total Liabilities
1293289
Quarters > 1 > balance Sheet > equity
7212726
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
-1841165
Quarters > 1 > cash Flow > depreciation
2118
Quarters > 1 > cash Flow > change In Working Capital
267614
Quarters > 1 > cash Flow > cash From Operations
-419842
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-737356
Quarters > 1 > cash Flow > cash From Financing
649194
Quarters > 1 > cash Flow > net Change In Cash
-524490
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
-0.01831581542631229
Quarters > 1 > ratios > PB
0.7275075768579037
Quarters > 1 > ratios > ROE
-25.52661781412465
Quarters > 1 > ratios > ROA
-21.64544736871496
Quarters > 1 > ratios > FCF
-419842
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-11.542048109965636
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
71055
Quarters > 2 > income Statement > cost Of Revenue
156066
Quarters > 2 > income Statement > gross Profit
-85011
Quarters > 2 > income Statement > operating Expenses
606262
Quarters > 2 > income Statement > operating Income
-606262
Quarters > 2 > income Statement > interest Expense
548
Quarters > 2 > income Statement > pretax Income
-1472863
Quarters > 2 > income Statement > net Income
-1472863
Quarters > 2 > income Statement > eps
-0.014976450112475162
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
98345268
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1470197
Quarters > 2 > income Statement > operating Margin
-853.2291886566744
Quarters > 2 > income Statement > total Other Income Expense Net
-866601
Quarters > 2 > income Statement > currency_symbol
CHF
Quarters > 2 > balance Sheet > cash
2825484
Quarters > 2 > balance Sheet > short Term Investments
6828
Quarters > 2 > balance Sheet > receivables
35361
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3197278
Quarters > 2 > balance Sheet > property Plant Equipment
40591
Quarters > 2 > balance Sheet > total Assets
9484654
Quarters > 2 > balance Sheet > payables
286135
Quarters > 2 > balance Sheet > short Term Debt
14796
Quarters > 2 > balance Sheet > long Term Debt
32800
Quarters > 2 > balance Sheet > total Liabilities
1188976
Quarters > 2 > balance Sheet > equity
8295678
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
-1472863
Quarters > 2 > cash Flow > depreciation
2118
Quarters > 2 > cash Flow > change In Working Capital
-17419
Quarters > 2 > cash Flow > cash From Operations
-598706
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
97991
Quarters > 2 > cash Flow > net Change In Cash
-516254
Quarters > 2 > cash Flow > currency_symbol
CHF
Quarters > 2 > ratios > PE
-0.014976450112475162
Quarters > 2 > ratios > PB
0.6188310334128206
Quarters > 2 > ratios > ROE
-17.754582566970413
Quarters > 2 > ratios > ROA
-15.528905956927897
Quarters > 2 > ratios > FCF
-598706
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-8.425951727535008
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1508
Quarters > 3 > income Statement > cost Of Revenue
1508
Quarters > 3 > income Statement > gross Profit
1508
Quarters > 3 > income Statement > operating Expenses
447134
Quarters > 3 > income Statement > operating Income
-445626
Quarters > 3 > income Statement > interest Expense
1486
Quarters > 3 > income Statement > pretax Income
-1189831
Quarters > 3 > income Statement > net Income
-1205736
Quarters > 3 > income Statement > eps
-0.012260554039490943
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
98342701
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1164543
Quarters > 3 > income Statement > operating Margin
-29550.79575596817
Quarters > 3 > income Statement > total Other Income Expense Net
-744205
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
3341738
Quarters > 3 > balance Sheet > short Term Investments
6496
Quarters > 3 > balance Sheet > receivables
15513
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3534867
Quarters > 3 > balance Sheet > property Plant Equipment
42709
Quarters > 3 > balance Sheet > total Assets
10671807
Quarters > 3 > balance Sheet > payables
253290
Quarters > 3 > balance Sheet > short Term Debt
14612
Quarters > 3 > balance Sheet > long Term Debt
34690
Quarters > 3 > balance Sheet > total Liabilities
1001031
Quarters > 3 > balance Sheet > equity
9670775
Quarters > 3 > balance Sheet > currency_symbol
CHF
Quarters > 3 > cash Flow > net Income
-1189831
Quarters > 3 > cash Flow > depreciation
23803
Quarters > 3 > cash Flow > change In Working Capital
438367
Quarters > 3 > cash Flow > cash From Operations
-25057
Quarters > 3 > cash Flow > capital Expenditures
3
Quarters > 3 > cash Flow > cash From Investing
-15904
Quarters > 3 > cash Flow > cash From Financing
-223
Quarters > 3 > cash Flow > net Change In Cash
-7442
Quarters > 3 > cash Flow > currency_symbol
CHF
Quarters > 3 > ratios > PE
-0.012260554039490943
Quarters > 3 > ratios > PB
0.5308249847814679
Quarters > 3 > ratios > ROE
-12.467832205795295
Quarters > 3 > ratios > ROA
-11.298330264031199
Quarters > 3 > ratios > FCF
-25060
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-16.618037135278513
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
410042
Annuals > 0 > income Statement > cost Of Revenue
854305
Annuals > 0 > income Statement > gross Profit
-444263
Annuals > 0 > income Statement > operating Expenses
2310970
Annuals > 0 > income Statement > operating Income
-2755233
Annuals > 0 > income Statement > interest Expense
3547
Annuals > 0 > income Statement > pretax Income
-4909342
Annuals > 0 > income Statement > net Income
7055787
Annuals > 0 > income Statement > eps
0.07174599442965424
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
98343985
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-4645678
Annuals > 0 > income Statement > operating Margin
-671.939215982753
Annuals > 0 > income Statement > total Other Income Expense Net
-2154109
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
3341738
Annuals > 0 > balance Sheet > short Term Investments
6496
Annuals > 0 > balance Sheet > receivables
15513
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3534867
Annuals > 0 > balance Sheet > property Plant Equipment
42709
Annuals > 0 > balance Sheet > total Assets
10671807
Annuals > 0 > balance Sheet > payables
253290
Annuals > 0 > balance Sheet > short Term Debt
14612
Annuals > 0 > balance Sheet > long Term Debt
34690
Annuals > 0 > balance Sheet > total Liabilities
1001031
Annuals > 0 > balance Sheet > equity
9670775
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
-4909342
Annuals > 0 > cash Flow > depreciation
260120
Annuals > 0 > cash Flow > change In Working Capital
-1228370
Annuals > 0 > cash Flow > cash From Operations
-5373608
Annuals > 0 > cash Flow > capital Expenditures
1272
Annuals > 0 > cash Flow > cash From Investing
4645211
Annuals > 0 > cash Flow > cash From Financing
104972
Annuals > 0 > cash Flow > net Change In Cash
-523743
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
0.07174599442965424
Annuals > 0 > ratios > PB
0.5633733355392924
Annuals > 0 > ratios > ROE
72.95989204588051
Annuals > 0 > ratios > ROA
66.11614134326081
Annuals > 0 > ratios > FCF
-5374880
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-13.108120631545061
Annuals > 0 > health Score
73
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1612953
Annuals > 1 > income Statement > cost Of Revenue
6931251
Annuals > 1 > income Statement > gross Profit
-5318298
Annuals > 1 > income Statement > operating Expenses
2673463
Annuals > 1 > income Statement > operating Income
-2242967
Annuals > 1 > income Statement > interest Expense
21607
Annuals > 1 > income Statement > pretax Income
-2500153
Annuals > 1 > income Statement > net Income
-10556227
Annuals > 1 > income Statement > eps
-0.1420611354405237
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
74307635
Annuals > 1 > income Statement > income Tax Expense
-2
Annuals > 1 > income Statement > EBITDA
-10255940
Annuals > 1 > income Statement > operating Margin
-139.0596626188116
Annuals > 1 > income Statement > total Other Income Expense Net
-257186
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
3865481
Annuals > 1 > balance Sheet > short Term Investments
848
Annuals > 1 > balance Sheet > receivables
151268
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4234605
Annuals > 1 > balance Sheet > property Plant Equipment
352936
Annuals > 1 > balance Sheet > total Assets
4641885
Annuals > 1 > balance Sheet > payables
984384
Annuals > 1 > balance Sheet > short Term Debt
547912
Annuals > 1 > balance Sheet > long Term Debt
70380
Annuals > 1 > balance Sheet > total Liabilities
3496420
Annuals > 1 > balance Sheet > equity
1145465
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
-10556227
Annuals > 1 > cash Flow > depreciation
305952
Annuals > 1 > cash Flow > change In Working Capital
213756
Annuals > 1 > cash Flow > cash From Operations
-7992411
Annuals > 1 > cash Flow > capital Expenditures
6842
Annuals > 1 > cash Flow > cash From Investing
-6842
Annuals > 1 > cash Flow > cash From Financing
5264596
Annuals > 1 > cash Flow > net Change In Cash
-3091605
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-0.1420611354405237
Annuals > 1 > ratios > PB
3.59386186308617
Annuals > 1 > ratios > ROE
-921.5669618888398
Annuals > 1 > ratios > ROA
-227.412505910853
Annuals > 1 > ratios > FCF
-7999253
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.959383813415518
Annuals > 1 > health Score
12
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1422438
Annuals > 2 > income Statement > cost Of Revenue
14623462
Annuals > 2 > income Statement > gross Profit
-13201024
Annuals > 2 > income Statement > operating Expenses
3756847
Annuals > 2 > income Statement > operating Income
-20520207
Annuals > 2 > income Statement > interest Expense
48897
Annuals > 2 > income Statement > pretax Income
-20804213
Annuals > 2 > income Statement > net Income
-20804213
Annuals > 2 > income Statement > eps
-0.46042436997432656
Annuals > 2 > income Statement > dividends Per Share
307496
Annuals > 2 > income Statement > shares Outstanding
45184865
Annuals > 2 > income Statement > income Tax Expense
264360
Annuals > 2 > income Statement > EBITDA
-20432172
Annuals > 2 > income Statement > operating Margin
-1442.608183977087
Annuals > 2 > income Statement > total Other Income Expense Net
-284006
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
6957086
Annuals > 2 > balance Sheet > short Term Investments
3165
Annuals > 2 > balance Sheet > receivables
598316
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
7828961
Annuals > 2 > balance Sheet > property Plant Equipment
398734
Annuals > 2 > balance Sheet > total Assets
8282050
Annuals > 2 > balance Sheet > payables
1276546
Annuals > 2 > balance Sheet > short Term Debt
572214
Annuals > 2 > balance Sheet > long Term Debt
87030
Annuals > 2 > balance Sheet > total Liabilities
3369139
Annuals > 2 > balance Sheet > equity
4912911
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
-20804213
Annuals > 2 > cash Flow > depreciation
323144
Annuals > 2 > cash Flow > change In Working Capital
157677
Annuals > 2 > cash Flow > cash From Operations
-16437185
Annuals > 2 > cash Flow > capital Expenditures
581
Annuals > 2 > cash Flow > cash From Investing
2972
Annuals > 2 > cash Flow > cash From Financing
3102688
Annuals > 2 > cash Flow > net Change In Cash
-13527750
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
-0.46042436997432656
Annuals > 2 > ratios > PB
0.5095230752195592
Annuals > 2 > ratios > ROE
-423.4600016161497
Annuals > 2 > ratios > ROA
-251.19641876105555
Annuals > 2 > ratios > FCF
-16437766
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-11.55605094914506
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2916308
Annuals > 3 > income Statement > cost Of Revenue
12818540
Annuals > 3 > income Statement > gross Profit
-9665235
Annuals > 3 > income Statement > operating Expenses
5840682
Annuals > 3 > income Statement > operating Income
-15505917
Annuals > 3 > income Statement > interest Expense
63012
Annuals > 3 > income Statement > pretax Income
-15351914
Annuals > 3 > income Statement > net Income
-15414926
Annuals > 3 > income Statement > eps
-0.45179006148536155
Annuals > 3 > income Statement > dividends Per Share
390189
Annuals > 3 > income Statement > shares Outstanding
34119666
Annuals > 3 > income Statement > income Tax Expense
63012
Annuals > 3 > income Statement > EBITDA
-14941292
Annuals > 3 > income Statement > operating Margin
-531.6968235179548
Annuals > 3 > income Statement > total Other Income Expense Net
154003
Annuals > 3 > income Statement > currency_symbol
CHF
Annuals > 3 > balance Sheet > cash
20484836
Annuals > 3 > balance Sheet > short Term Investments
17145
Annuals > 3 > balance Sheet > receivables
324421
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
21941776
Annuals > 3 > balance Sheet > property Plant Equipment
542100
Annuals > 3 > balance Sheet > total Assets
22541784
Annuals > 3 > balance Sheet > payables
1787287
Annuals > 3 > balance Sheet > short Term Debt
287698
Annuals > 3 > balance Sheet > long Term Debt
194320
Annuals > 3 > balance Sheet > total Liabilities
5610684
Annuals > 3 > balance Sheet > equity
16931100
Annuals > 3 > balance Sheet > currency_symbol
CHF
Annuals > 3 > cash Flow > net Income
-15351914
Annuals > 3 > cash Flow > depreciation
347613
Annuals > 3 > cash Flow > change In Working Capital
-761567
Annuals > 3 > cash Flow > cash From Operations
-14705185
Annuals > 3 > cash Flow > capital Expenditures
31549
Annuals > 3 > cash Flow > cash From Investing
-30313
Annuals > 3 > cash Flow > cash From Financing
16402824
Annuals > 3 > cash Flow > net Change In Cash
1789796
Annuals > 3 > cash Flow > currency_symbol
CHF
Annuals > 3 > ratios > PE
-0.45179006148536155
Annuals > 3 > ratios > PB
0.11164245066179988
Annuals > 3 > ratios > ROE
-91.0450354672762
Annuals > 3 > ratios > ROA
-68.38378896719088
Annuals > 3 > ratios > FCF
-14736734
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.053215915465719
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.01399781323522963
Valuation > metrics > PB
0.9871079742320077
Valuation > final Score
70
Valuation > verdict
1.3% Undervalued
Profitability > metrics > ROE
-26.4700250312366
Profitability > metrics > ROA
-66.69831236118887
Profitability > metrics > Net Margin
-53.06254205355941
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2302986210582935
Risk > metrics > Interest Coverage
-1474.947033898305
Risk > final Score
-5840
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.715676558881966
Liquidity > metrics > Quick Ratio
5.715676558881966
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3476
Prev Risks > 1
-4365
Prev Risks > 2
-1140
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:47.679Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-16
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-03-05
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-12-04
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0183
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-09-30
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.02
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-15
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-0.01
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2024-12-31
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-0.01
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-11-21
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
CHF
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
-0.01
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-100
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-09-30
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CHF
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
-0.01
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-18
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
CHF
Earnings History > 8 > eps Actual
-0.03
Earnings History > 8 > eps Estimate
-0.03
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2023-12-31
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CHF
Earnings History > 9 > eps Actual
-0.03
Earnings History > 9 > eps Estimate
-0.03
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-11-29
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
CHF
Earnings History > 10 > eps Actual
-0.03
Earnings History > 10 > eps Estimate
-0.03
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-08-10
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
CHF
Earnings History > 11 > eps Actual
-0.04
Earnings History > 11 > eps Estimate
-0.04
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-05-11
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CHF
Earnings History > 12 > eps Actual
-0.04
Earnings History > 12 > eps Estimate
-0.04
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-03-30
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CHF
Earnings History > 13 > eps Actual
-0.21
Earnings History > 13 > eps Estimate
-0.21
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-11-11
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CHF
Earnings History > 14 > eps Actual
-0.09
Earnings History > 14 > eps Estimate
-0.09
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-07-29
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CHF
Earnings History > 15 > eps Actual
-0.19
Earnings History > 15 > eps Estimate
-0.13
Earnings History > 15 > eps Difference
-0.06
Earnings History > 15 > surprise Percent
-46.1538
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-05-05
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CHF
Earnings History > 16 > eps Actual
-0.15
Earnings History > 16 > eps Estimate
-0.15
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-03-09
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
CHF
Earnings History > 17 > eps Actual
-0.13
Earnings History > 17 > eps Estimate
-0.1
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-30
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-11-03
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
CHF
Earnings History > 18 > eps Actual
-0.11
Earnings History > 18 > eps Estimate
-0.13
Earnings History > 18 > eps Difference
0.02
Earnings History > 18 > surprise Percent
15.3846
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-08-05
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
CHF
Earnings History > 19 > eps Actual
-0.14
Earnings History > 19 > eps Estimate
-0.12
Earnings History > 19 > eps Difference
-0.02
Earnings History > 19 > surprise Percent
-16.6667
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-05-05
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
CHF
Earnings History > 20 > eps Actual
-0.08
Earnings History > 20 > eps Estimate
-0.1
Earnings History > 20 > eps Difference
0.02
Earnings History > 20 > surprise Percent
20
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2021-03-11
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CHF
Earnings History > 21 > eps Actual
-0.08
Earnings History > 21 > eps Estimate
-0.08
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-11-03
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CHF
Earnings History > 22 > eps Actual
-0.12
Earnings History > 22 > eps Estimate
-0.12
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-08-12
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CHF
Earnings History > 23 > eps Actual
-0.12
Earnings History > 23 > eps Estimate
-0.12
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-04-08
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CHF
Earnings History > 24 > eps Actual
-0.27
Earnings History > 24 > eps Estimate
-0.16
Earnings History > 24 > eps Difference
-0.11
Earnings History > 24 > surprise Percent
-68.75
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CHF
Earnings History > 25 > eps Actual
-0.29
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.29
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-04-30
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CHF
Earnings History > 26 > eps Actual
-0.15
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.15
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-01-08
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CHF
Earnings History > 27 > eps Actual
0.1
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.1
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-03-31
Earnings History > 28 > report Date
2018-05-04
Earnings History > 28 > date
2018-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CHF
Earnings History > 28 > eps Actual
-0.11
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.11
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-06-30
Earnings History > 29 > report Date
2017-09-29
Earnings History > 29 > date
2017-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CHF
Earnings History > 29 > eps Actual
-0.14
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.14
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-03-31
Earnings History > 30 > report Date
2017-05-16
Earnings History > 30 > date
2017-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CHF
Earnings History > 30 > eps Actual
-0.18
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.18
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2016-06-30
Earnings History > 31 > report Date
2016-09-30
Earnings History > 31 > date
2016-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CHF
Earnings History > 31 > eps Actual
-0.11
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.11
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2016-03-31
Earnings History > 32 > report Date
2016-05-02
Earnings History > 32 > date
2016-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
CHF
Earnings History > 32 > eps Actual
-0.13
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.13
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2007-06-30
Earnings History > 33 > report Date
2007-07-25
Earnings History > 33 > date
2007-06-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
-3.3
Earnings History > 33 > eps Estimate
-1.6
Earnings History > 33 > eps Difference
-1.7
Earnings History > 33 > surprise Percent
-106.25
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Stock Price
CHF0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AADXN.SW Addex Therapeutics (SIX) pre-market CHF0.0564 vol 1.51M: watch liquidity Meyka
Read more →Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia Yahoo Finance UK
Read more →Showing 2 of 5
(Last Updated 2025-09-30)
Rating:
SELL
$
Analyst Picks
Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Addex Therapeutics Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
-0.0183
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
CHF 0
Cost Of Revenue
CHF 0
Gross Profit
CHF 0
Operating Expenses
CHF 0
Operating Income
CHF 0
Interest Expense
CHF 0
Pretax Income
CHF 0
Net Income
CHF 0
Income Tax Expense
CHF 0
EBITDA
CHF 0
Total Other Income Expense Net
CHF 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
CHF 0
Short Term Investments
CHF 0
Receivables
CHF 0
Inventories
CHF 0
Total Current Assets
CHF 0
Property Plant Equipment
CHF 0
Total Assets
CHF 0
Payables
CHF 0
Short Term Debt
CHF 0
Long Term Debt
CHF 0
Total Liabilities
CHF 0
Equity
CHF 0
(Last Updated 2025-09-30)
Net Income
CHF 0
Depreciation
CHF 0
Change In Working Capital
CHF 0
Cash From Operations
CHF 0
Capital Expenditures
CHF 0
Cash From Investing
CHF 0
Cash From Financing
CHF 0
Net Change In Cash
CHF 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.